85 related articles for article (PubMed ID: 22238264)
1. Interactome-transcriptome integration for predicting distant metastasis in breast cancer.
Garcia M; Millat-Carus R; Bertucci F; Finetti P; Birnbaum D; Bidaut G
Bioinformatics; 2012 Mar; 28(5):672-8. PubMed ID: 22238264
[TBL] [Abstract][Full Text] [Related]
2. Detection of driver protein complexes in breast cancer metastasis by large-scale transcriptome-interactome integration.
Garcia M; Finetti P; Bertucci F; Birnbaum D; Bidaut G
Methods Mol Biol; 2014; 1101():67-85. PubMed ID: 24233778
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype.
Schroth W; Winter S; Büttner F; Goletz S; Faißt S; Brinkmann F; Saladores P; Heidemann E; Ott G; Gerteis A; Alscher MD; Dippon J; Schwab M; Brauch H; Fritz P
Breast Cancer Res Treat; 2016 Jan; 155(1):85-97. PubMed ID: 26650824
[TBL] [Abstract][Full Text] [Related]
4. Genefu: an R/Bioconductor package for computation of gene expression-based signatures in breast cancer.
Gendoo DM; Ratanasirigulchai N; Schröder MS; Paré L; Parker JS; Prat A; Haibe-Kains B
Bioinformatics; 2016 Apr; 32(7):1097-9. PubMed ID: 26607490
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive value.
Lehmann BD; Ding Y; Viox DJ; Jiang M; Zheng Y; Liao W; Chen X; Xiang W; Yi Y
BMC Cancer; 2015 Mar; 15():179. PubMed ID: 25886164
[TBL] [Abstract][Full Text] [Related]
6. A favorable role of prolactin in human breast cancer reveals novel pathway-based gene signatures indicative of tumor differentiation and favorable patient outcome.
Hachim IY; Shams A; Lebrun JJ; Ali S
Hum Pathol; 2016 Jul; 53():142-52. PubMed ID: 26980025
[TBL] [Abstract][Full Text] [Related]
7. Relative Prognostic and Predictive Value of Gene Signature and Histologic Grade in Estrogen Receptor-Positive, HER2-Negative Breast Cancer.
Iwamoto T; Kelly C; Mizoo T; Nogami T; Motoki T; Shien T; Taira N; Hayashi N; Niikura N; Fujiwara T; Doihara H; Matsuoka J
Clin Breast Cancer; 2016 Apr; 16(2):95-100.e1. PubMed ID: 26631838
[TBL] [Abstract][Full Text] [Related]
8. Copy number alterations that predict metastatic capability of human breast cancer.
Zhang Y; Martens JW; Yu JX; Jiang J; Sieuwerts AM; Smid M; Klijn JG; Wang Y; Foekens JA
Cancer Res; 2009 May; 69(9):3795-801. PubMed ID: 19336569
[TBL] [Abstract][Full Text] [Related]
9. 21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer.
Turashvili G; Chou JF; Brogi E; Morrow M; Dickler M; Norton L; Hudis C; Wen HY
Breast Cancer Res Treat; 2017 Nov; 166(1):69-76. PubMed ID: 28702894
[TBL] [Abstract][Full Text] [Related]
10. Genes and functions from breast cancer signatures.
Huang S; Murphy L; Xu W
BMC Cancer; 2018 Apr; 18(1):473. PubMed ID: 29699511
[TBL] [Abstract][Full Text] [Related]
11. Integrating protein-protein interaction networks with gene-gene co-expression networks improves gene signatures for classifying breast cancer metastasis.
van den Akker EB; Verbruggen B; Heijmans BT; Beekman M; Kok JN; Slagboom PE; Reinders MJ
J Integr Bioinform; 2011 Dec; 8(2):188. PubMed ID: 22180387
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of a 92-probe signature in breast cancer.
Akter S; Choi TG; Nguyen MN; Matondo A; Kim JH; Jo YH; Jo A; Shahid M; Jun DY; Yoo JY; Nguyen NN; Seo SW; Ali L; Lee JS; Yoon KS; Choe W; Kang I; Ha J; Kim J; Kim SS
Oncotarget; 2015 Jun; 6(17):15662-80. PubMed ID: 25883221
[TBL] [Abstract][Full Text] [Related]
13. Ovarian Cancer Differential Interactome and Network Entropy Analysis Reveal New Candidate Biomarkers.
Ayyildiz D; Gov E; Sinha R; Arga KY
OMICS; 2017 May; 21(5):285-294. PubMed ID: 28375712
[TBL] [Abstract][Full Text] [Related]
14. CrossLink: a novel method for cross-condition classification of cancer subtypes.
Ma C; Sastry KS; Flore M; Gehani S; Al-Bozom I; Feng Y; Serpedin E; Chouchane L; Chen Y; Huang Y
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):549. PubMed ID: 27556419
[TBL] [Abstract][Full Text] [Related]
15. The prognostic potential of alternative transcript isoforms across human tumors.
Trincado JL; Sebestyén E; Pagés A; Eyras E
Genome Med; 2016 Aug; 8(1):85. PubMed ID: 27535130
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of multifocal breast cancer using the 70-gene signature in clinical low-risk patients enrolled in the EORTC 10041/BIG 03-04 MINDACT trial.
Aalders KC; Kuijer A; Straver ME; Slaets L; Litiere S; Viale G; Van't Veer LJ; Glas AM; Delorenzi M; van Dalen T; Tryfonidis K; Piccart MJ; Cardoso F; Rutgers EJ;
Eur J Cancer; 2017 Jul; 79():98-105. PubMed ID: 28477490
[TBL] [Abstract][Full Text] [Related]
17. The molecular basis of breast cancer pathological phenotypes.
Heng YJ; Lester SC; Tse GM; Factor RE; Allison KH; Collins LC; Chen YY; Jensen KC; Johnson NB; Jeong JC; Punjabi R; Shin SJ; Singh K; Krings G; Eberhard DA; Tan PH; Korski K; Waldman FM; Gutman DA; Sanders M; Reis-Filho JS; Flanagan SR; Gendoo DM; Chen GM; Haibe-Kains B; Ciriello G; Hoadley KA; Perou CM; Beck AH
J Pathol; 2017 Feb; 241(3):375-391. PubMed ID: 27861902
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of a BCSC-associated MicroRNA Signature in Hormone Receptor-Positive HER2-Negative Breast Cancer.
Gong C; Tan W; Chen K; You N; Zhu S; Liang G; Xie X; Li Q; Zeng Y; Ouyang N; Li Z; Zeng M; Zhuang S; Lau WY; Liu Q; Yin D; Wang X; Su F; Song E
EBioMedicine; 2016 Sep; 11():199-209. PubMed ID: 27566954
[TBL] [Abstract][Full Text] [Related]
19. A novel gene expression signature for bone metastasis in breast carcinomas.
Savci-Heijink CD; Halfwerk H; Koster J; van de Vijver MJ
Breast Cancer Res Treat; 2016 Apr; 156(2):249-59. PubMed ID: 26965286
[TBL] [Abstract][Full Text] [Related]
20. PPFIA1 is upregulated in liver metastasis of breast cancer and is a potential poor prognostic indicator of metastatic relapse.
Yang J; Wu NN; Huang DJ; Luo YC; Huang JZ; He HY; Lu HL; Song WL
Tumour Biol; 2017 Jul; 39(7):1010428317713492. PubMed ID: 28720060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]